P., Wang, R., Lee, H
Acknowledgements The authors would like to thank Henrik Kim Nielsen, Jens Heisterberg, and Karen Hauda (Novo Nordisk A/S, Denmark), and Gina MacNeil (Novo Nordisk Inc, United States) for review of, and input to, the manuscript, as well as Tina stergaard, Sisse Lakner Schmidt, and Michala Cronberg (Novo Nordisk A/S, Denmark) for help with physical stability analyses
Standard MSCs mainly repair bone, cartilage, and muscle
Minor wounds often show substantial progress within 2-4 weeks, while more significant injuries may require 6-8 weeks of consistent use
Regulating mast cell activity, helping to manage symptoms in MCAS patients
Stable Gastricpentadecapeptide BPC 157, L-Arginine, L-NAME